Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio

Journal of Obesity

Volumn 2013, Issue , 2013, Pages

  Vega, Gloria Lena ^a   Grundy, Scott M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; TRIACYLGLYCEROL; APOLIPOPROTEIN B;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; BODY MASS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; APOLIPOPROTEINS B; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

MLCS; MLOWN;

EID: 84875550388     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2013/409679     Document Type: Article

References (40)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002 106 3143 3421
2. Alberti, Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., Fruchart J., James W. P. T., Loria C. M., Smith S. C., Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation 2009 120 16 1640 1645 2-s2.0-70350245011 10.1161/CIRCULATIONAHA.109.192644
3. Cameron A. J., Sicree R. A., Zimmet P. Z., Alberti K. G. M. M., Tonkin A. M., Balkau B., Tuomilehto J., Chitson P., Shaw J. E., Cut-points for waist circumference in Europids and South Asians. Obesity 2010 18 10 2039 2046 2-s2.0-77957160318 10.1038/oby.2009.455
4. Considine R. V., Sinha M. K., Heiman M. L., Kriauciunas A., Stephens T. W., Nyce M. R., Ohannesian J. P., Marco C. C., Mckee L. J., Bauer T. L., Caro J. F., Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine 1996 334 5 292 295 2-s2.0-13344295079 10.1056/NEJM199602013340503 (Pubitemid 26033933)
5. Ruhl C. E., Everhart J. E., Ding J., Goodpaster B. H., Kanaya A. M., Simonsick E. M., Tylavsky F. A., Harris T. B., Serum leptin concentrations and body adipose measures in older black and white adults. American Journal of Clinical Nutrition 2004 80 3 576 583 2-s2.0-4544235466 (Pubitemid 41115520)
6. Mapfei, Halaas, Ravussin, Pratley, Lee, Zhangs, Fei, Kim, Lallone, Ranganathan, Kern, Friedman, Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1995 1 11 1155 1161 2-s2.0-0028845877
7. Couillard C., Mauriège P., Imbeault P., Prud'homme D., Nadeau A., Tremblay A., Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia. International Journal of Obesity 2000 24 6 782 788 2-s2.0-0034119354 (Pubitemid 30339278)
8. Lilja, Rolandsson, Shaw, Pauvaday, Cameron, Tuomilehto, Alberti, Zimmet, Söderberg, Higher leptin levels in Asian Indians than Creoles and Europids: a potential explanation for increased metabolic risk. International Journal of Obesity 2010 34 5 878 885 2-s2.0-77952292557 10.1038/ijo.2010.19
9. Klein, Coppack, Mohamed-Ali, Landt, Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996 45 3 984 987 2-s2.0-0029974877 (Pubitemid 26225518)
10. Van Harmelen V., Reynisdottir S., Eriksson P., Thörne A., Hoffstedt J., Lönnqvist F., Arner P., Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998 47 6 913 917 2-s2.0-0031802865 10.2337/diabetes.47.6.913 (Pubitemid 28255665)
11. Kondo H., Shimomura L., Matsukawa Y., Kumada M., Takahashi M., Matsuda M., Ouchi N., Kihara S., Kawamoto T., Sumitsuji S., Funahashi T., Matsuzawa Y., Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2002 51 7 2325 2328 2-s2.0-0036303146 (Pubitemid 34729044)
12. Matsuzawa Y., Funahashi T., Kihara S., Shimomura I., Adiponectin and metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 1 29 33 2-s2.0-0345861775 10.1161/01.ATV.0000099786.99623.EF (Pubitemid 38082408)
13. Turer A. T., Khera A., Ayers C. R., Adipose tissue mass and location affect circulating adiponectin levels. Diabetologia 2011 54 10 2515 2524 2-s2.0-80054094657 10.1007/s00125-011-2252-z
14. Clarenbach J. J., Grundy S. M., Palacio N., Vega G. L., Relationship of apolipoprotein B levels to the number of risk factors for metabolic syndrome. Journal of Investigative Medicine 2007 55 5 237 247 2-s2.0-35048827381 10.2310/6650.2007.00004 (Pubitemid 47555942)
15. Vega G. L., Chandalia M., Szczepaniak L. S., Grundy S. M., Metabolic correlates of nonalcoholic fatty liver in women and men. Hepatology 2007 46 3 716 722 2-s2.0-34548787759 10.1002/hep.21727 (Pubitemid 47436117)
16. Levy J. C., Matthews D. R., Hermans M. P., Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998 21 12 2191 2192 2-s2.0-0031737373 (Pubitemid 28549174)
17. Zhu S., Heymsfield S. B., Toyoshima H., Wang Z., Pietrobelli A., Heshka S., Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors. American Journal of Clinical Nutrition 2005 81 2 409 415 2-s2.0-14544290616 (Pubitemid 43073342)
18. Park J. Y., Chong A. Y., Cochran E. K., Kleiner D. E., Haller M. J., Schatz D. A., Gorden P., Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy. Journal of Clinical Endocrinology and Metabolism 2008 93 1 26 31 2-s2.0-38149012112 10.1210/jc.2007-1856
19. Oral E. A., Simha V., Ruiz E., Andewelt A., Premkumar A., Snell P., Wagner A. J., DePaoli A. M., Reitman M. L., Taylor S. I., Gorden P., Garg A., Leptin-replacement therapy for lipodystrophy. The New England Journal of Medicine 2002 346 8 570 578 2-s2.0-0037148928 10.1056/NEJMoa012437 (Pubitemid 34438818)
20. Zelissen P. M., Stenlof K., Lean M. E., Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial. Diabetes, Obesity and Metabolism 2005 7 6 755 761 2-s2.0-27744596187 10.1111/j.1463-1326.2005.00468.x (Pubitemid 41601081)
21. Mantzoros C. S., Magkos F., Brinkoetter M., Leptin in human physiology and pathophysiology. American Journal of Physiology 2011 301 4 E567 E584
22. Strobel A., Issad T., Camoin L., Ozata M., Strosberg D., A leptin missense mutation associated with hypogonadism and morbid obesity. Nature Genetics 1998 18 3 213 215 2-s2.0-0032014836
23. Clément K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., Gourmelen M., Dina C., Chambaz J., Lacorte J., Basdevant A., Bougnères P., Lebouc Y., Froguel P., Guy-Grand B., A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998 392 6674 398 401 2-s2.0-0344450708 10.1038/32911 (Pubitemid 28168737)
24. Farooqi I. S., Jebb S. A., Langmack G., Lawrence E., Cheetham C. H., Prentice A. M., Hughes I. A., McCamish M. A., O'Rahilly S., Effects of recombinant leptin therapy in a child with congenital leptin deficiency. The New England Journal of Medicine 1999 341 12 879 884 2-s2.0-0033575993 10.1056/NEJM199909163411204 (Pubitemid 29427050)
25. Ryan A. S., Berman D. M., Nicklas B. J., Sinha M., Gingerich R. L., Meneilly G. S., Egan J. M., Elahi D., Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003 26 8 2383 2388 2-s2.0-0042023742 10.2337/diacare.26.8.2383 (Pubitemid 36993330)
26. Qiao L., Zou C., van der Westhuyzen D. R., Shao J., Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. Diabetes 2008 57 7 1824 1833 2-s2.0-48249117609 10.2337/db07-0435
27. Combs T. P., Pajvani U. B., Berg A. H., A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004 145 367 383 (Pubitemid 38094532)
28. Yamauchi T., Kamon J., Waki H., Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. The Journal of Biological Chemistry 2003 278 4 2461 2468 (Pubitemid 36801322)
29. Bauche I. B., El Mkadem S. A., Pottier A., Senou M., Many M., Rezsohazy R., Penicaud L., Maeda N., Funahashi T., Brichard S. M., Overexpression of adiponectin targeted to adipose tissue in transgenic mice: impaired adipocyte differentiation. Endocrinology 2007 148 4 1539 1549 2-s2.0-33947354951 10.1210/en.2006-0838 (Pubitemid 46457100)
30. Baratta R., Amato S., Degano C., Farina M. G., Patanè G., Vigneri R., Frittitta L., Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2665 2671 2-s2.0-2942670648 10.1210/jc.2003-031777 (Pubitemid 38766347)
31. Vergès B., Petit J. M., Duvillard L., Dautin G., Florentin E., Galland F., Gambert P., Adiponectin is an important determinant of ApoA-I catabolism. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 6 1364 1369 2-s2.0-33745050936 10.1161/01.ATV.0000219611.50066.bd (Pubitemid 44305383)
32. Chan D. C., Barrett P. H. R., Ooi E. M. M., Ji J., Chan D. T., Watts G. F., Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein a-l kinetics in obese and nonobese men. Journal of Clinical Endocrinology and Metabolism 2009 94 3 989 997 2-s2.0-62349092938 10.1210/jc.2008-1457
33. Schneider J. G., Von Eynatten M., Schiekofer S., Nawroth P. P., Dugi K. A., Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 2005 28 9 2181 2186 2-s2.0-24144446132 10.2337/diacare.28.9.2181 (Pubitemid 41242465)
34. Clarenbach J. J., Vega G. L., Adams-Huet B., Considine R. V., Ricks M., Sumner A. E., Variability in postheparin hepatic lipase activity is associated with plasma adiponectin levels in African Americans. Journal of Investigative Medicine 2007 55 4 187 194 2-s2.0-34848866918 10.2310/6650.2007.07001 (Pubitemid 47495862)
35. Finucane F. M., Luan J., Wareham N. J., Correlation of the leptin: adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 2009 52 11 2345 2349 2-s2.0-70349887559 10.1007/s00125-009-1508-3
36. Oda N., Imamura S., Fujita T., Uchida Y., Inagaki K., Kakizawa H., Hayakawa N., Suzuki A., Takeda J., Horikawa Y., Itoh M., The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 2008 57 2 268 273 2-s2.0-38049075329 10.1016/j.metabol.2007.09.011
37. Wildman R. P., Muntner P., Reynolds K., McGinn A. P., Rajpathak S., Wylie-Rosett J., Sowers M. R., The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Archives of Internal Medicine 2008 168 15 1617 1624 2-s2.0-49449106657 10.1001/archinte.168.15.1617
38. Blüher M., The distinction of metabolically "healthy" from "unhealthy" obese individuals. Current Opinion in Lipidology 2010 21 38 43
39. Brochu M., Tchernof A., Dionne I. J., What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? The Journal of Clinical Endocrinology & Metabolism 2001 86 1020 1025 (Pubitemid 32322976)
40. Stefan N., Kantartzis K., Machann J., Schick F., Thamer C., Rittig K., Balletshofer B., Machicao F., Fritsche A., Häring H., Identification and characterization of metabolically benign obesity in humans. Archives of Internal Medicine 2008 168 15 1609 1616 2-s2.0-49449092403 10.1001/archinte.168.15.1609